Coalesce
Device
NuVasive, Inc.
Total Payments
$23,625
Transactions
3
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $12,500 | 1 | 0 |
| 2020 | $11,125 | 2 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12,500 | 1 | 52.9% |
| Royalty or License | $11,125 | 2 | 47.1% |
Payments by Type
Research
$12,500
1 transactions
General
$11,125
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $12,500 | 0 |
Top Doctors Receiving Payments for Coalesce
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Jacksonville, FL | $12,500 | 1 |
| , MD | Neurological Surgery | Metairie, LA | $11,125 | 2 |
Ad
Manufacturing Companies
- NuVasive, Inc. $23,625
Product Information
- Type Device
- Total Payments $23,625
- Total Doctors 1
- Transactions 3
About Coalesce
Coalesce is a device associated with $23,625 in payments to 1 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is NuVasive, Inc..
Payment data is available from 2020 to 2021. In 2021, $12,500 was paid across 1 transactions to 0 doctors.
The most common payment nature for Coalesce is "Unspecified" ($12,500, 52.9% of total).
Coalesce is associated with 1 research study, including "A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine" ($12,500).